GlassScriptPhysician profile
Paul Kuder
NPI 1114347283
$1,077.89
in general payments reported to CMS, 2019-2025
25 companies · $362 in 2025
The $362 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90.45 · 2020: $96.63 · 2021: $76.77 · 2022: $107 · 2023: $62.44 · 2024: $283 · 2025: $362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $707.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $707.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $105.43 | 2021-2023 | |
| Astellas Pharma US INC | $101.23 | 2024-2025 | Veozah |
| Exeltis, USA INC. | $91.83 | 2024-2025 | Slynd |
| Hologic Sales and Service, LLC | $79.58 | 2019-2025 | Myosure Tissue Removal Device, Novasure, Aptima |
| Organon LLC | $72.18 | 2022-2023 | Nexplanon |
| Mayne Pharma Commercial LLC | $71.04 | 2024-2025 | |
| Millicent US INC | $66.04 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Pfizer INC. | $55.79 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $55.71 | 2020-2024 | |
| Avion Pharmaceuticals | $43.07 | 2020-2021 | |
| Biogen, INC. | $40.90 | 2025 | Zurzuvae |
| Roche Diagnostics Corporation | $38.93 | 2019 | |
| Coopersurgical, INC. | $31.89 | 2019-2025 | Paragard T 380a |
| Sumitomo Pharma America, INC. | $28.51 | 2025 | Myfembree |
| Boston Scientific Corporation | $21.92 | 2025 | Bulkamid |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $21.46 | 2020 | |
| Daiichi Sankyo INC. | $21.29 | 2020 | |
| Exact Sciences Corporation | $20.14 | 2025 | The Cologuard Plus Collection Kit |
| Medtronic, INC. | $19.52 | 2022 | |
| Aspira Women'S Health INC | $19.29 | 2022 | |
| Ferring Pharmaceuticals INC. | $16.40 | 2023 | Rebyota |
| Cranial Technologies, INC | $15.15 | 2024 | Doc Band |
| Agile Therapeutics, INC. | $14.99 | 2024 | Twirla |
| Merck Sharp & Dohme LLC | $13.75 | 2019 | |
| Allergan, INC. | $11.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Kuder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.